What does a low serum albumin level indicate?

What Low Albumin Means

Low serum albumin is primarily a marker of inflammation and disease severity—not malnutrition—and signals increased risk of hospitalization, complications, and death across virtually all clinical contexts. 1

Clinical Significance and Risk Stratification

Low albumin carries profound prognostic implications that escalate with severity:

• Albumin < 35 g/L is associated with higher perioperative morbidity and mortality and represents one of the strongest patient-related risk factors for adverse surgical outcomes 1
• Albumin < 30 g/L markedly increases postoperative complications, infections, and impairs wound healing 1
• Albumin < 25 g/L defines severe hypoalbuminemia and correlates with substantially higher risk of death 1
• Each 0.1 g/dL decrease in serum albumin is associated with a 6% rise in mortality risk, a 5% increase in hospitalization days, and a 5% higher technique-failure rate in dialysis patients 2, 3
• Albumin ≈ 15 g/L (profound depletion) predicts an 89% rise in morbidity and a 137% rise in mortality for each 1 g/dL decrement 1, 4

Even small decrements matter: a decline of ≥0.1 g/dL per month from baseline signals a higher risk profile compared with a stable low albumin level 1

What Low Albumin Actually Reflects

Inflammation is the Primary Driver

Albumin functions as a negative acute-phase reactant—it drops during illness regardless of nutritional intake. 1, 5

• Inflammatory cytokines (IL-6, TNF-α) directly suppress hepatic albumin synthesis, producing an inverse relationship between C-reactive protein (CRP) and serum albumin even when protein and caloric intake are adequate 1
• In otherwise healthy subjects, serum albumin and prealbumin levels remain normal despite marked nutrient deprivation until the extremes of starvation (BMI <12 or >6 weeks of starvation) 5
• When albumin is low in sick patients, this cannot be assumed to reflect nutritional deprivation—it reflects disease severity and inflammatory burden 1, 5

Other Contributing Mechanisms

Beyond inflammation, low albumin may indicate:

• Protein losses: Nephrotic syndrome (urine albumin-to-creatinine ratio ≥300 mg/g with edema), protein-losing enteropathy, or peritoneal dialysate losses 1
• Impaired hepatic synthesis: Chronic liver disease, hepatic congestion from heart failure, or cirrhosis reduce albumin production capacity 1
• Volume overload (hemodilution): Fluid overload independently lowers measured serum albumin; assess for edema, ascites, or pleural effusion 1
• True malnutrition: Only after excluding inflammation, protein losses, and volume issues should inadequate protein-energy intake be considered 1

Algorithmic Evaluation of Low Albumin

When you encounter low albumin, follow this sequence:

Step 1: Measure CRP Immediately

• An elevated CRP indicates that inflammation is the primary driver of low albumin 1
• Albumin values should always be interpreted alongside CRP to distinguish inflammatory from nutritional effects 1

Step 2: Assess Volume Status

• Look for clinical signs of fluid overload: edema, ascites, pleural effusion, elevated jugular venous pressure 1
• Postoperative patients typically experience a 10–15 g/L drop in albumin due to transcapillary loss and inflammation 1

Step 3: Quantify Protein Losses

• Obtain urine albumin-to-creatinine ratio; ≥300 mg/g with edema suggests nephrotic-syndrome-related protein loss 1
• In peritoneal dialysis patients, quantify albumin loss in dialysate 1
• Consider stool alpha-1-antitrypsin if protein-losing enteropathy is suspected

Step 4: Evaluate Hepatic Synthetic Function

• Check prothrombin time/INR, bilirubin, and other liver function tests to gauge hepatic albumin production capacity 1

Step 5: Nutritional Assessment (Only After Excluding Above)

• Use Subjective Global Assessment (SGA)—it outperforms serum albumin alone for detecting protein-energy wasting 1
• Anthropometric measurements (mid-arm circumference, triceps skinfold thickness, mid-arm muscle circumference) provide reliable estimates of nutritional status 1
• Bioimpedance analysis, when available, adds quantitative insight into body composition and fluid status 1

Management Priorities

Focus on treating the underlying cause of hypoalbuminemia rather than the low albumin level itself. 4

Treat Underlying Inflammation

• Identify and treat infections or inflammatory conditions 1
• Serial CRP measurements can be used to monitor therapeutic response 1
• Nutritional support alone does not raise albumin while inflammation persists 1

Correct Volume Overload

• Initiate diuretics and fluid restriction to achieve euvolemia 1
• Reducing hemodilution helps raise serum albumin concentration 1

Minimize Protein Losses

• Use ACE inhibitors or ARBs to treat proteinuria when appropriate 1
• Optimize peritoneal dialysis prescriptions to limit albumin loss in dialysate 1

Nutritional Support (When True Malnutrition is Confirmed)

• Target protein intake of 1.2–1.3 g/kg/day for dialysis patients 1, 4
• Target energy intake of 30–35 kcal/kg/day 1
• Aim for normalized protein nitrogen appearance ≥0.9 g/kg/day 1
• High-protein foods: lean meats, fish, eggs, dairy, legumes, and soy products 1

When NOT to Give Albumin Infusion

Albumin infusion is not recommended for routine correction of low serum albumin levels. 1, 4

Avoid albumin infusion for:

• First-line volume resuscitation in critically ill patients 1
• Prevention or treatment of intradialytic hypotension 1
• Preterm neonates with respiratory distress, pediatric cardiac surgery, or in conjunction with diuretics for fluid removal 1

Specific Indications for Albumin Infusion

Give albumin only in these scenarios:

• Large-volume paracentesis (>5 L) in cirrhosis: 8 g albumin per liter of ascites removed 1, 6
• Spontaneous bacterial peritonitis: 1.5 g/kg on day 1, then 1.0 g/kg on day 3 1, 6
• Hepatorenal syndrome-AKI: 1 g/kg on day 1, then 20–40 g daily with vasopressors until creatinine normalizes (max 14 days) 1
• Symptomatic hypovolemia (prolonged capillary refill, tachycardia, hypotension, oliguria) 1

Risks of Albumin Infusion

• Pulmonary edema and fluid overload, especially when targeting specific albumin concentrations 1
• Hypotension, hemodilution requiring transfusion, and anaphylaxis 1
• Approximate cost of $130 per 25 g vial 1

Monitoring and Target Goals

Frequency

• In dialysis patients, monitor serum albumin at least every 4 months 2, 1, 3
• Increase monitoring frequency during acute illness or when albumin is declining 1, 3

Target Levels

• Dialysis patients: aim for ≥4.0 g/dL (using bromcresol-green method) 1
• General population: maintain albumin at or above the lower limit of the laboratory's normal range 2, 1
• A stable or rising serum albumin concentration is more desirable than a declining one, even if both values are within normal range 3

Interpretation

• Rising albumin suggests a shift toward anabolism; falling albumin indicates catabolism or worsening disease 1, 3
• Trends should be interpreted alongside CRP to differentiate inflammatory from nutritional effects 1

Laboratory Measurement Considerations

• The bromcresol-green assay overestimates albumin by ~0.2 g/dL in cirrhotic patients; immunoassay is preferred for accurate quantification 1
• Laboratories should apply assay-specific reference ranges because methodology influences reported values 2, 1, 3

Common Pitfalls to Avoid

• Assuming hypoalbuminemia is solely due to malnutrition when inflammation may be the primary driver 4
• Failing to recognize that albumin is a negative acute-phase reactant that decreases during inflammation 4, 5
• Not considering the multiple non-nutritional factors (inflammation, volume status, protein losses, hepatic dysfunction) that affect serum albumin levels 4
• Relying solely on albumin infusion to correct the underlying problem rather than addressing the cause 4
• Overlooking the significance of small but progressive decreases in albumin levels 3
• Using albumin as a nutritional marker in the presence of inflammation—it reflects disease severity rather than protein intake 1